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Introduction: Fabry disease is rare X-linked, recessive lysosomal storage disorder expressed as defi-
ciency in enzyme α-galactosidase A that leads to progressive accumulation of globotriaosylceramide 
and related glycosphingolipids in various tissues. In cardiac tissues, progressive globotriaosylcera-
mide accumulation leads to irreversible cardiac damage.1,2 Males are primarily affected by Fabry dis-
ease, but female heterozygotes may also have symptoms.3
Case report: Our patient is 47-years-old who has been suffering from chronic kidney disease since 
he was 23 years old. Only twelve years later he developed end-stage renal disease and has been un-
dergoing regular haemodialysis in Dialysis Centre Prijedor (Bosnia and Herzegovina). He started his 
journey towards kidney transplantation in 2014 in University Hospital Centre Rijeka, which was per-
formed in May 2018. In 2014, during pretransplantation workup, echocardiography was performed re-
vealing concentric cardiac hypertrophy without left ventricle outflow tract obstruction (Figure 1 and 
Figure 2) associated with contractility and diastolic filling impairment. Following suspicion on Fabry 
disease, diagnosis was made by measuring α-galactosidase enzyme activity in leukocytes and molec-
ular genetic testing of GLA gene mutation. Enzyme replacement therapy was started with intravenous 
infusion of recombinant α-galactosidase A (agalsidase beta).
Figure 1. Echocardiography image, apical four-chamber view 
showing thickened intraventricular septum and lateral wall of left 
ventricle.
Figure 2. Echocardiography image, parasternal long axis view 
showing thickened intraventricular septum and inferolateral wall of 
left ventricle with prominent papillary muscle.
Conclusion: Renal disease and echocardiographic features of hypertrophic cardiomyopathy combined 
with electrocardiographic and clinical criteria should be considered as “red flags” for Fabry disease.
